Phase I Drug Combination Trial Design: Walking the Tightrope
Phase I Drug Combination Trial Design: Walking the Tightrope
Drug combination strategies are used in the palliative and curative settings for patients with cancer. Before a specific drug is incorporated into such a combination treatment strategy, it has to be explored using the clinical drug development route. The first critical step is the design of a combination phase I …